News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Results from Landmark Randomized Clinical Trial of Ardian's Catheter-Based Treatment for Hypertension To Be Presented at American Heart Association Scientific Sessions 2010


11/15/2010 12:27:40 PM

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Ardian, Inc., a pioneer in catheter-based therapies for hypertension and related conditions, today announced that results from the company’s Symplicity HTN-2 trial will be the subject of a late breaking clinical trial presentation this week at the American Heart Association Scientific Sessions 2010 in Chicago, Ill.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES